In one instance, the disclosure is a moldable, biocompatible, bioactive, and resorbable hip implant made to be implanted after femoral head ostectomy. The hip implant can be configured so that a portion of the implant can fit into the femoral canal after the femoral head is excised, and another portion can fit into the joint space. The hip implant can be configured to have a honeycomb structure capable of receiving and retaining materials such as antibiotics, stem cells, and platelet rich plasma for treatment after femoral head ostectomy. The resorbable material comprising the hip implant can degrade or dissolve over time and be resorbed by the body while scar tissue forms a pseudoarthrosis in place of the resorbed hip implant.
